
    
      Trial Objectives

        1. The primary objective of this study is to evaluate the long-term safety of theophylline
           in patients with PHP.

        2. The secondary objectives of this study are to evaluate changes in BMI, hormone
           resistance and epiphyseal closure associated with theophylline treatment of patients
           with PHP.

      Study Design The proposed study is a single center, 24-month open label extension clinical
      trial for patients with PHP who complete the randomized clinical trial.
    
  